0
     

Report Added
Report already added
North America Clinical Trials Market 2021-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Country: Trend Forecast and Growth Opportunity

North America Clinical Trials Market 2021-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Country: Trend Forecast and Growth Opportunity

North America clinical trials market is projected to grow by 6.9% annually in the forecast period and reach $ 39,268.7 million by 2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence on chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&D investments.

Highlighted with 29 tables and 75 figures, this 136-page report “North America Clinical Trials Market 2021-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America clinical trials market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
•Market Structure
•Growth Drivers
•Restraints and Challenges
•Emerging Product Trends & Market Opportunities
•Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America clinical trials market in every aspect of the classification from perspectives of Product Category, Phase, Design, Service Type, Indication, End User, and Country.

Based on Product Category, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Trials of Drugs
oSmall Molecule Drugs
oVaccines
oCell & Gene Therapy
oOther Drugs
•Trials of Devices
•Trials of Procedures

Based on Phase, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Phase I
•Phase II
•Phase III
•Phase IV

By Design, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Interventional Studies
oRandomized Control Trial
oAdaptive Clinical Trial
oNon-randomized Control Trial
•Observational Studies
oCohort Study
oCase Control Study
oCross Sectional Study
oEcological Study
•Expanded Access Trials

By Service Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Protocol Designing
•Site Identification
•Patient Recruitment
•Laboratory Services
•Bioanalytical Testing Services
•Clinical Trial Data Management Services
•Clinical Trial Supply & Logistic Services
•Decentralized Clinical Trial Services
•Medical Device Testing Services
•Other Clinical Trial Services

By Indication, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Oncology
•Infectious Diseases
•Cardiology
•Obesity
•Diabetes
•Neurology
•Immunology
•Pain Management
•Other Indications

By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Pharmaceutical and Biotechnological Companies
•Clinical Research Organizations
•Clinical Testing Laboratories
•Other End Users

Geographically, the following national/local markets are fully investigated:
•U.S.
•Canada
•Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Phase, Design, and Indication over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:
Accell Clinical Research LLC
Charles River Laboratory
ClinDatrix Inc
Clinipace
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
ICON PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America
Novo Nordisk AS
PAREXEL International Corporation
Pfizer Inc.
Pharmaceutical Product Development LLC
PRA Health Sciences
Sanofi SA
SGS SA
Syneos Health Inc.
Wuxi AppTec Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents

1 Introduction8
1.1 Industry Definition and Research Scope8
1.1.1 Industry Definition8
1.1.2 Research Scope9
1.2 Research Methodology12
1.2.1 Overview of Market Research Methodology12
1.2.2 Market Assumption13
1.2.3 Secondary Data13
1.2.4 Primary Data13
1.2.5 Data Filtration and Model Design14
1.2.6 Market Size/Share Estimation15
1.2.7 Research Limitations16
1.3 Executive Summary17
2 Market Overview and Dynamics20
2.1 Market Size and Forecast20
2.1.1 Impact of COVID-19 on World Economy22
2.1.2 Impact of COVID-19 on the Market24
2.2 Major Growth Drivers26
2.3 Market Restraints and Challenges33
2.4 Emerging Opportunities and Market Trends36
2.5 Porter’s Fiver Forces Analysis40
3 Segmentation of North America Market by Product Category44
3.1 Market Overview by Product Category44
3.2 Trials of Drugs46
3.2.1 Small Molecule Drugs47
3.2.2 Vaccines48
3.2.3 Cell & Gene Therapy49
3.2.4 Other Drugs50
3.3 Trials of Devices51
3.4 Trials of Procedures52
4 Segmentation of North America Market by Phase53
4.1 Market Overview by Phase53
4.2 Phase I55
4.3 Phase II56
4.4 Phase III57
4.5 Phase IV58
5 Segmentation of North America Market by Design59
5.1 Market Overview by Design59
5.2 Interventional Studies61
5.2.1 Randomized Control Trial63
5.2.2 Adaptive Clinical Trial64
5.2.3 Non-randomized Control Trial65
5.3 Observational Studies66
5.3.1 Cohort Study68
5.3.2 Case Control Study69
5.3.3 Cross Sectional Study70
5.3.4 Ecological Study71
5.4 Expanded Access Trials72
6 Segmentation of North America Market by Service Type73
6.1 Market Overview by Service Type73
6.2 Protocol Designing75
6.3 Site Identification76
6.4 Patient Recruitment77
6.5 Laboratory Services78
6.6 Bioanalytical Testing Services79
6.7 Clinical Trial Data Management Services80
6.8 Clinical Trial Supply & Logistic Services81
6.9 Decentralized Clinical Trial Services82
6.10 Medical Device Testing Services83
6.11 Other Clinical Trial Services84
7 Segmentation of North America Market by Indication85
7.1 Market Overview by Indication85
7.2 Oncology87
7.3 Infectious Diseases88
7.4 Cardiology89
7.5 Obesity90
7.6 Diabetes91
7.7 Neurology92
7.8 Immunology93
7.9 Pain Management94
7.10 Other Indications95
8 Segmentation of North America Market by End User96
8.1 Market Overview by End User96
8.2 Pharmaceutical and Biotechnological Companies98
8.3 Clinical Research Organizations99
8.4 Clinical Testing Laboratories100
8.5 Other End Users101
9 North America Market 2021-2031 by Country102
9.1 Overview of North America Market102
9.2 U.S.105
9.3 Canada108
9.4 Mexico110
10 Competitive Landscape112
10.1 Overview of Key Vendors112
10.2 New Product Launch, Partnership, Investment, and M&A116
10.3 Company Profiles117
Accell Clinical Research LLC117
Charles River Laboratory119
ClinDatrix Inc120
Clinipace121
Eli Lilly and Company122
F. Hoffmann-La Roche Ltd.123
ICON PLC124
IQVIA Holdings, Inc.125
Laboratory Corporation of America126
Novo Nordisk AS127
PAREXEL International Corporation128
Pfizer Inc.129
Pharmaceutical Product Development LLC130
PRA Health Sciences131
Sanofi SA132
SGS SA133
Syneos Health Inc.134
Wuxi AppTec Inc.135
RELATED REPORTS136

List of Tables:

Table 1. Snapshot of North America Clinical Trials Market in Balanced Perspective, 2021-203118
Table 2. Total Number of Registered Clinical Studies Worldwide, 2010-202121
Table 3. World Economic Outlook, 2021-203123
Table 4. World Health Spending by Region, $ bn, 2013-202032
Table 5. Main Product Trends and Market Opportunities in North America Clinical Trials Market36
Table 6. North America Clinical Trials Market by Product Category, 2021-2031, $ mn44
Table 7. North America Clinical Trials Market: Trials of Drugs by Drug Type, 2021-2031, $ mn46
Table 8. North America Clinical Trials Market by Phase, 2021-2031, $ mn53
Table 9. North America Clinical Trials Market by Design, 2021-2031, $ mn59
Table 10. North America Clinical Trials Market: Interventional Studies by Segment, 2021-2031, $ mn62
Table 11. North America Clinical Trials Market: Observational Studies by Segment, 2021-2031, $ mn67
Table 12. North America Clinical Trials Market by Service Type, 2021-2031, $ mn73
Table 13. North America Clinical Trials Market by Indication, 2021-2031, $ mn85
Table 14. North America Clinical Trials Market by End User, 2021-2031, $ mn96
Table 15. North America Clinical Trials Market by Country, 2021-2031, $ mn103
Table 16. U.S. Clinical Trials Market by Phase, 2021-2031, $ mn107
Table 17. U.S. Clinical Trials Market by Design, 2021-2031, $ mn107
Table 18. U.S. Clinical Trials Market by Indication, 2021-2031, $ mn107
Table 19. Canada Clinical Trials Market by Phase, 2021-2031, $ mn109
Table 20. Canada Clinical Trials Market by Design, 2021-2031, $ mn109
Table 21. Canada Clinical Trials Market by Indication, 2021-2031, $ mn109
Table 22. Mexico Clinical Trials Market by Phase, 2021-2031, $ mn111
Table 23. Mexico Clinical Trials Market by Design, 2021-2031, $ mn111
Table 24. Mexico Clinical Trials Market by Indication, 2021-2031, $ mn111
Table 25. Percentage of Registered Studies by Location (as of February 24, 2022)114
Table 26. Percentage of Recruiting Studies by Location (as of February 24, 2022)114
Table 27. Accell Clinical Research LLC: Company Snapshot117
Table 28. Accell Clinical Research LLC: Business Segmentation118
Table 29. Accell Clinical Research LLC: Product Portfolio118

Report Title: North America Clinical Trials Market 2021-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Country: Trend Forecast and Growth Opportunity


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Wound Care in Turkey

Wound Care in Turkey

Wound Care in Tunisia

Wound Care in Tunisia

Wound Care in Slovenia

Wound Care in Slovenia

Wound Care in Slovakia

Wound Care in Slovakia

Wound Care in Serbia

Wound Care in Serbia

Wound Care in China

Wound Care in China